Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy

被引:60
作者
Rapiti, E [1 ]
Porta, D [1 ]
Forastiere, F [1 ]
Fusco, D [1 ]
Perucci, CA [1 ]
机构
[1] Lazio Reg Hlth Author, Dept Epidemiol, Rome, Italy
关键词
acquired immunodeficiency syndrome; socioeconomic status; survival; intravenous drug use; gender;
D O I
10.1097/00001648-200009000-00003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We estimated the AIDS survival by neighborhood socioeconomic status before (1993-1995) and after (1996-1997) the introduction of highly active antiretroviral therapy in Rome, Italy, in a retrospective cohort of persons with AIDS followed through July 31, 1998. Participants included 1,474 persons with AIDS residing in Rome who were diagnosed in 1993-1997. We calculated hazard ratios (HRs) of death for two diagnostic periods (before and after highly active antiretroviral therapy was introduced) by neighborhood socioeconomic status categorized into four levels (level I = highest socioeconomic status), using the Cox model and adjusting fur gender, age, intravenous drug use, CD4 cell count at diagnosis, AIDS-defining disease, and hospital of diagnosis. Thirty-four per cent of persons with AIDS (N = 503) had survived as of mid-1998. For persons with AIDS diagnosed in 1993-1995, we found little difference in the risk of death by neighborhood socioeconomic status. For 1996-1997, the risk of death was greater for persons with lower neighborhood socioeconomic status, especially for levels III and IV [HR = 2.81 (95% confidence interval = 1.38-5.76), and HR = 2.55 (95% confidence interval = 1.27-5.14), respectively, compared with level I]. Stratified analyses showed that the greatest difference was found for women and drug users. In conclusion, even in a country with universal health coverage that Provides therapy at no cost, differences in survival of persons with AIDS have emerged by neighborhood socioeconomic status since highly active antiretroviral therapy was introduced. Inequalities in health care access or in medical management, or poor adherence to treatment, could explain the observed heterogeneity.
引用
收藏
页码:496 / 501
页数:6
相关论文
共 50 条
  • [21] Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy
    Gérard, L
    Galicier, L
    Boulanger, E
    Quint, L
    Lebrette, MG
    Mortier, E
    Meignin, V
    Oksenhendler, E
    [J]. AIDS, 2003, 17 (01) : 81 - 87
  • [22] Survival of AIDS patients in Croatia prior to the introduction of combined antiretroviral therapy with protease inhibitors
    Begovac, J
    Kniewald, T
    Ugarkovic, N
    Lisic, M
    Sonicki, Z
    Jazbec, A
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2000, 16 (08) : 741 - 744
  • [23] Survival of AIDS patients in Croatia prior to the introduction of combined antiretroviral therapy with protease inhibitors
    J. Begovac
    T. Kniewald
    N. Ugarković
    M. Lisić
    Z. Sonicki
    A. Jazbec
    [J]. European Journal of Epidemiology, 2000, 16 : 741 - 744
  • [24] The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland
    Seikkula, Heikki A.
    Kaipia, Antti J.
    Ryynanen, Heidi
    Seppa, Karri
    Pitkaniemi, Janne M.
    Malila, Nea K.
    Bostrom, Peter J.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (05) : 891 - 898
  • [25] Profile analysis of patients with HIV/AIDS hospitalized after the introduction of antiretroviral therapy
    Nunes, Altacilio Aparecido
    Caliani, Lais Scalone
    Nunes, Maira Souza
    da Silva, Anderson Soares
    de Mello, Luane Marques
    [J]. CIENCIA & SAUDE COLETIVA, 2015, 20 (10): : 3191 - 3198
  • [26] Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy
    Chiou, CC
    Groll, AH
    Mavrogiorgos, N
    Wood, LV
    Walsh, TJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (05) : 388 - 392
  • [27] Influence of highly active antiretroviral therapy on the evolution of AIDS-associated Kaposi's sarcoma
    Alsina, MM
    Bulla, F
    Conill, C
    Mallolas, J
    Pérez-Cuevas, JB
    Lecha, M
    [J]. MEDICINA CLINICA, 2000, 115 (19): : 736 - 737
  • [28] Effect of Highly Active Antiretroviral Therapy on Incident AIDS Using Calendar Period as an Instrumental Variable
    Cain, Lauren E.
    Cole, Stephen R.
    Greenland, Sander
    Brown, Todd T.
    Chmiel, Joan S.
    Kingsley, Lawrence
    Detels, Roger
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (09) : 1124 - 1132
  • [29] Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis
    Velasco, Maria
    Castilla, Virgilio
    Sanz, Jose
    Gaspar, Gabriel
    Condes, Emilia
    Barros, Carlos
    Cervero, Miguel
    Torres, Rafael
    Guijarro, Carlos
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (02) : 148 - 152
  • [30] Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis
    McNaghten, AD
    Hanson, DL
    Jones, JL
    Dworkin, MS
    Ward, JW
    [J]. AIDS, 1999, 13 (13) : 1687 - 1695